Measuring systemic levels of C components and C activation products, in addition to studying C3, C4 and CH50 [14], may be useful to predict diagnosis, disease activity and/or prognosis for C-associated diseases, including some kidney diseases [3, 6]. This evidence concerns the gene C4A and kidney disorder.